tiprankstipranks
Trending News
More News >
Covalon Technologies (TSE:COV)
:COV
Canadian Market
Advertisement

Covalon Technologies (COV) Price & Analysis

Compare
32 Followers

COV Stock Chart & Stats

C$2.08
-C$0.04(-1.22%)
At close: 4:00 PM EST
C$2.08
-C$0.04(-1.22%)

Covalon Technologies News

COV FAQ

What was Covalon Technologies’s price range in the past 12 months?
Covalon Technologies lowest stock price was C$1.88 and its highest was C$3.89 in the past 12 months.
    What is Covalon Technologies’s market cap?
    Covalon Technologies’s market cap is C$53.19M.
      When is Covalon Technologies’s upcoming earnings report date?
      Covalon Technologies’s upcoming earnings report date is Jan 22, 2026 which is in 58 days.
        How were Covalon Technologies’s earnings last quarter?
        Covalon Technologies released its earnings results on Aug 21, 2025. The company reported C$0 earnings per share for the quarter, missing the consensus estimate of C$0.04 by -C$0.04.
          Is Covalon Technologies overvalued?
          According to Wall Street analysts Covalon Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Covalon Technologies pay dividends?
            Covalon Technologies pays a Notavailable dividend of C$0.15 which represents an annual dividend yield of N/A. See more information on Covalon Technologies dividends here
              What is Covalon Technologies’s EPS estimate?
              Covalon Technologies’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Covalon Technologies have?
              Covalon Technologies has 27,418,077 shares outstanding.
                What happened to Covalon Technologies’s price movement after its last earnings report?
                Covalon Technologies reported an EPS of C$0 in its last earnings report, missing expectations of C$0.04. Following the earnings report the stock price went down -16.729%.
                  Which hedge fund is a major shareholder of Covalon Technologies?
                  Currently, no hedge funds are holding shares in TSE:COV

                  Covalon Technologies Stock Smart Score

                  1
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -45.71%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  9.01%
                  Trailing 12-Months
                  Asset Growth
                  32.84%
                  Trailing 12-Months

                  Company Description

                  Covalon Technologies

                  Covalon Technologies Ltd. is a Canadian medical technology company that specializes in advanced wound care solutions and infection management products. The company operates primarily within the healthcare sector, focusing on innovative solutions designed to improve patient outcomes and streamline clinical practices. Covalon's core products include antimicrobial dressings, surgical solutions, and a range of medical devices that utilize its proprietary technology to enhance healing and reduce the risk of infections.

                  Covalon Technologies (COV) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Oncolytics Biotech
                  Oncolytics Biotech
                  Helix BioPharma
                  Microbix Biosystms
                  Medmira
                  Sernova
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis